Prevalence and risk f actors influencing the development of arterial hypertension in patients with a gout
Background. Cardiovascular diseases (CVD) is the leading cause of death for gout. Arterial hypertension is a proven CVD risk factor (CVD-RF).Objective. To assess the factors influencing on development of an arterial hypertension in patients with a gout. Subjects and methods. 286 male patients fulfil...
Main Authors: | E. I. Markelova, M. S. Eliseev, T. V. Popkova, E. V. Ilinyh, S. I. Glukhova, V. G. Barskova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2021-01-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2971 |
Similar Items
-
Arterial hypertension in gout patients: Pathogenesis bases, clinical value, diagnosis
by: E I Markelova, et al.
Published: (2012-12-01) -
VALUE OF 24-HOUR BLOOD PRESSURE MONITORING IN THE DIAGNOSIS OF ARTERIAL HYPERTENSION IN PATIENTSWITH GOUT
by: E I Markelova, et al.
Published: (2010-02-01) -
Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01) -
Characteristics of endothelial dysfunction in patients with gout comorbid with arterial hypertension
by: N. A. Zolotariova, et al.
Published: (2016-06-01) -
Characteristics of endothelial dysfunction in patients with gout comorbid with arterial hypertension
by: N. A. Zolotariova, et al.
Published: (2016-06-01)